
News|Articles|November 1, 2012
Dimethyl fumarate: A fumaric acid ester under investigation for treatment of relapsing-remitting multiple sclerosis
Dimethyl fumarate is an investigational drug being studied for the treatment of relapsing-remitting multiple sclerosis (RRMS).
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Patient-facing EHR tool improves lung cancer screening identification
2
New therapies on the way to lower Lp(a), a cardiovascular risk factor
3
Children’s Hospital of Philadelphia and Soar Autism Center launch early autism care network
4
Newer biologics show strong drug survival for psoriasis patients
5






















































